Oncologic Outcomes of Robotic Radical Hysterectomy (RRH) for Patients with Early-Stage Cervical Cancer: Experience at a Referral Cancer Center.


Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 14 04 2020
accepted: 26 07 2020
pubmed: 30 8 2020
medline: 11 5 2021
entrez: 30 8 2020
Statut: ppublish

Résumé

To evaluate oncologic outcomes of early stage cervical cancer patients who underwent robotic radical hysterectomy (RRH) in a referral center, a retrospective analysis was performed. From January 2010 to December 2018, medical records of stage IA2-IIA1 cervical cancer patients, who underwent radical hysterectomy at our institute, were retrospectively reviewed. We focused our analysis on those who underwent RRH. A total of 198 patients were included in the final analysis. Median follow up was 52 months. At last follow-up, 188 (94.9%) women were disease-free, 9 (4.5%) had died, and 1 (0.5%) was alive with recurrent disease. At 4.5 years, PFS was 93.1% (SE ± 2.1) and OS was 95.1% (SE ± 1.8). Stratified by tumor size, PFS for tumor < 2 cm versus tumor ≥ 2 cm was statistically different (96.8% ± 2.3 and 87.9% ± 4.1 respectively, p = 0.01), as well as OS (100% and 89.8% ± 40 respectively, p = 0.01).Stratified by evidence of tumor at time of robotic surgery, PFS was statistically different in women with no residual tumor after conisation versus those with residual disease (100% ± 2.5 and 90.8% ± 2.8 respectively, p = 0.04). A recurrence occurred in 11 patients (5.6%). Based on our results, we could speculate that robotic approach, along with some technical precautions to avoid spillage, might be safe as primary treatment of early-stage cervical cancer, especially for tumor < 2 cm and in case of no evidence of disease at time of radical hysterectomy after previous conisation.

Identifiants

pubmed: 32860175
doi: 10.1245/s10434-020-09016-1
pii: 10.1245/s10434-020-09016-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1819-1829

Références

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jema lA. Global cancer statistics 2018: GLOBOCAN estimates of cancer incidence and mortality for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
American College of Obstetricians and Gynecologists. ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas. Number 35, May 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002;78(1):79–91.
Gaffney DK, Erickson-Wittmann BA, Jhingran A, et al. Appropriateness Criteria
doi: 10.1016/j.ijrobp.2010.11.005
Monk BJ, Tewari KS, Koh WJ. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol. 2007;25(20):2952–65.
doi: 10.1200/JCO.2007.10.8324
Querleu D, Cibula D, Abu-Rustum NR. 2017 Update on the Querleu-Morrow Classification of Radical Hysterectomy. Ann Surg Oncol. 2017;24(11):3406–126.
Wang YZ, Deng L, Xu HC, Zhang Y, Liang ZQ. Laparoscopy versus laparotomy for the management of early stage cervical cancer. BMC Cancer. 2015;15:928.
doi: 10.1186/s12885-015-1818-4
Lee EJ, Kang H, Kim DH. A comparative study of laparoscopic radical hysterectomy with radical abdominal hysterectomy for early-stage cervical cancer: a long-term follow-up study. Eur J Obstet Gynecol Reprod Biol. 2011;156(1):83–6.
doi: 10.1016/j.ejogrb.2010.12.016
Nam JH, Park JY, Kim DY, Kim JH, Kim YM, Kim YT. Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort study. Ann Oncol. 2012;23(4):903–11.
doi: 10.1093/annonc/mdr360
Sert BM, Boggess JF, Ahmad S, et al. Robot-assisted versus open radical hysterectomy: a multi-institutional experience for early-stage cervical cancer. Eur J Surg Oncol. 2016;42(4):513–22.
doi: 10.1016/j.ejso.2015.12.014
Ramirez PT, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379(20):1895–904.
doi: 10.1056/NEJMoa1806395
Querleu D, Morrow CP. Classification of radical hysterectomy. Gynecol Oncol. 2009;115(2):314–5.
doi: 10.1016/j.ygyno.2009.07.027
Cibula D, Pötter R, Planchamp F, et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer. Int J Gynecol Cancer. 2018;28(4):641–55.
doi: 10.1097/IGC.0000000000001216
Bhatla N, Berek J S, Cuello Fredes M, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynecol Obstet. 2019;145:129–35.
doi: 10.1002/ijgo.12749
Galaal K, Bryant A, Fisher AD, Al-Khaduri M, Kew F, Lopes AD. Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev. 2012;(9) CD006655. PMID: 22972096
Walker JL, Piedmonte MR, Spirtos NM, et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 study. J Clin Oncol. 2012;27(32):5331–6.
doi: 10.1200/JCO.2009.22.3248
Jørgensen SL, Mogensen O, Wu CS, Korsholm M, Lund K, Jensen PT. Survival after a nationwide introduction of robotic surgery in women with early-stage endometrial cancer: a population-based prospective cohort study. Eur J Cancer. 2019;109:1–11.
doi: 10.1016/j.ejca.2018.12.004
Shah CA, Beck T, Liao JB, Giannakopoulos NV, Veljovich D, Paley P. Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer. J Gynecol Oncol. 2017;28(6):e82.
doi: 10.3802/jgo.2017.28.e82
National Comprehensive Cancer Network (NCCN). Cervical Cancer Version 1. 2018; 2017.
Zhou J, Xiong BH, Ma L, Cheng Y, Huang W, Zhao L. Robotic vs. laparoscopic radical hysterectomy for cervical cancer: a meta-analysis. Int J Med Robot. 2016;12(1):145–54.
Pergialiotis V, Rodolakis A, Christakis D, Thomakos N, Vlachos G, Antsaklis A. Laparoscopically assisted vaginal radical hysterectomy: systematic review of the literature. J Minim Invasive Gynecol. 2013;20(6):745–53.
doi: 10.1016/j.jmig.2013.04.021
Shazly SAM, Murad MH, Dowdy SC, Gostout BS, Famuyide AO. Robotic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis. Gynecol Oncol. 2015;138(2):457–71.
doi: 10.1016/j.ygyno.2015.06.009
Frumovitz M, Dos Reis R, Sun CC, et al. Comparison of total laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer. Obstet Gynecol. 2007;110(1):96–102.
doi: 10.1097/01.AOG.0000268798.75353.04
Cao T, Feng Y, Huang Q, Wan T, Liu J. Prognostic and safety roles in laparoscopic versus abdominal radical hysterectomy in cervical cancer: a meta-analysis. J Laparoendosc Adv Surg Tech. 2015;25(12):990–8.
doi: 10.1089/lap.2015.0390
Zhao Y, Hang B, Xiong GW, Zhang XW. Laparoscopic radical hysterectomy in early stage cervical cancer: a systematic review and meta-analysis. J Laparoendosc Adv Surg Tech. 2017;27(11):1132–44.
doi: 10.1089/lap.2017.0022
Diver E, Hinchcliff E, Gockley A, et al. Minimally invasive radical hysterectomy for cervical cancer is associated with reduced morbidity and similar survival outcomes compared with laparotomy. J Min Invasive Gynecol. 2017;24(3):402–6.
doi: 10.1016/j.jmig.2016.12.005
Diver E, Hinchcliff E, Gockley A, et al. Minimally invasive radical hysterectomy for cervical cancer is associated with reduced morbidity and similar survival outcomes compared with laparotomy. J Min Invasive Gynecol. https://doi.org/10.1016/j.jmig.2016.12.005 . 2017;24(3):402–6.
Park DA, Yun JE, Kim SW, Lee SH. Surgical and clinical safety and effectiveness of robot-assisted laparoscopic hysterectomy compared to conventional laparoscopy and laparotomy for cervical cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2017;43(6):994–1002.
doi: 10.1016/j.ejso.2016.07.017
Zhang S sha, Ding T, Cui Z hui, Lv Y, Jiang R. Efficacy of robotic radical hysterectomy for cervical cancer compared with that of open and laparoscopic surgery: a separate meta-analysis of high-quality studies. Med (United States) Medicine. 2019;98:4.
Hoogendam JP, Verheijen RHM, Wegner I, Zweemer RP. Oncological outcome and long-term complications in robot-assisted radical surgery for early stage cervical cancer: an observational cohort study. BJOG An Int J Obstet Gynaecol. 2014;121(12):1538–45.
doi: 10.1111/1471-0528.12822
Malzoni M, Tinelli R, Cosentino F, Fusco A, Malzoni C. Total laparoscopic radical hysterectomy versus abdominal radical hysterectomy with lymphadenectomy in patients with early cervical cancer: our experience. Ann Surg Oncol. 2009;16(5):1316–23.
doi: 10.1245/s10434-009-0342-7
Soliman PT, Frumovitz M, Sun CC, et al. Radical hysterectomy: a comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology. Gynecol Oncol. 2011;123(2):333–6.
doi: 10.1016/j.ygyno.2011.08.001
Zanagnolo V, Minig L, Rollo D, et al. Clinical and oncologic outcomes of robotic versus abdominal radical hysterectomy for women with cervical cancer: experience at a referral cancer center. Int J Gynecol Cancer. 2016;26(3):568–74.
doi: 10.1097/IGC.0000000000000645
Zanagnolo V, Minig L, Cárdenas-Rebollo JM, et al. Robotic versus open radical hysterectomy in women with locally advanced cervical cancer after neoadjuvant chemotherapy: a single-institution experience of surgical and oncologic outcomes. J Minim Invasive Gynecol. 2016;23(6):909–16.
doi: 10.1016/j.jmig.2016.04.014
Obermair A, Gebski V, Frumovitz M, et al. A Phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol. 2008;15(5):584–8.
doi: 10.1016/j.jmig.2008.06.013
Melamed A, Margul DJ, Chen L, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer. N Engl J Med. 379(20):1905–14.
Matsuo K, Machida H, Mandelbaum RS, Konishi I, Mikami M. Validation FIGO 2018 cervical cancer. Gynecol Oncol. 2019, 152 (1), 87–93
doi: 10.1016/j.ygyno.2018.10.026
Ayhan A, Aslan K, Bulut AN, et al. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease? Eur J Obstet Gynecol Reprod Biol. 2019;240:209–14.
doi: 10.1016/j.ejogrb.2019.07.002
National Comprehensive Cancer Network, Cohen PA, Jhingran A, Oaknin A, Denny L. NCCN Clinical Practice Guidelines in Oncology. Cervical cancer. Lancet. 2019;393(10167):169–82.
Kim SI, Cho JH, Seol A, et al. Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1–IIA2 cervical cancer. Gynecol Oncol. 2019;153(1):3–12.
doi: 10.1016/j.ygyno.2019.01.008
Uppal S, Rebecca Liu J, Kevin Reynolds R, Rice LW, Spencer RJ. Trends and comparative effectiveness of inpatient radical hysterectomy for cervical cancer in the United States (2012–2015). Gynecol Oncol. 2019;152(1):133–8.
doi: 10.1016/j.ygyno.2018.09.027
Cusimano MC, Baxter NN, Gien LT, et al. Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer. Am J Obstet Gynecol. 2019;221(6):619.e1–619.e24.
doi: 10.1016/j.ajog.2019.07.009
Alfonzo E, Wallin E, Ekdahl L, et al. No survival difference between robotic and open radical hysterectomy for women with early-stage cervical cancer: results from a nationwide population-based cohort study. Eur J Cancer. 2019;116:169–77.
doi: 10.1016/j.ejca.2019.05.016
Falconer H, Palsdottir K, Stalberg K, et al. Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial. Int J Gynecol Cancer. 2019;29(6):1072–6.
doi: 10.1136/ijgc-2019-000558
Chiva L, Zanagnolo V, Kucukmetin A, et al. SUCCOR study. An international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 (FIGO 2009, < 4 cm) cervical cancer operated in 2013–2014. Int J Gynecol Cancer. 2019:29:A1–2.

Auteurs

Vanna Zanagnolo (V)

Department of Gynecology Oncology, Robotic Gynecologic Cancer Surgery Unit, IEO, European Institute of Oncology IRCCS, Milan, 20141, Milan, Italy. vanna.zanagnolo@ieo.it.

Clara Baroni (C)

Department of Clinical and Experimental Medicine, Division of Obstetrics and Gynecology, University of Pisa, Pisa, Italy.

Maria Teresa Achilarre (MT)

Department of Gynecology Oncology, Robotic Gynecologic Cancer Surgery Unit, IEO, European Institute of Oncology IRCCS, Milan, 20141, Milan, Italy.

Alessia Aloisi (A)

Department of Gynecology Oncology, Robotic Gynecologic Cancer Surgery Unit, IEO, European Institute of Oncology IRCCS, Milan, 20141, Milan, Italy.

Ilaria Betella (I)

Department of Gynecology Oncology, Robotic Gynecologic Cancer Surgery Unit, IEO, European Institute of Oncology IRCCS, Milan, 20141, Milan, Italy.

Stefano Bogliolo (S)

Department of Gynecology Oncology, Robotic Gynecologic Cancer Surgery Unit, IEO, European Institute of Oncology IRCCS, Milan, 20141, Milan, Italy.

Annalisa Garbi (A)

Department of Gynecology Oncology, Robotic Gynecologic Cancer Surgery Unit, IEO, European Institute of Oncology IRCCS, Milan, 20141, Milan, Italy.

Matteo Maruccio (M)

Department of Gynecology Oncology, Robotic Gynecologic Cancer Surgery Unit, IEO, European Institute of Oncology IRCCS, Milan, 20141, Milan, Italy.

Francesco Multinu (F)

Department of Gynecology Oncology, Robotic Gynecologic Cancer Surgery Unit, IEO, European Institute of Oncology IRCCS, Milan, 20141, Milan, Italy.

Giovanni Aletti (G)

Department of Gynecology Oncology, Robotic Gynecologic Cancer Surgery Unit, IEO, European Institute of Oncology IRCCS, Milan, 20141, Milan, Italy.

Angelo Maggioni (A)

Department of Gynecology Oncology, Robotic Gynecologic Cancer Surgery Unit, IEO, European Institute of Oncology IRCCS, Milan, 20141, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH